These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 15087378

  • 21. Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer.
    Domagala P, Wokolorczyk D, Cybulski C, Huzarski T, Lubinski J, Domagala W.
    Breast Cancer Res Treat; 2012 Apr; 132(3):937-45. PubMed ID: 21701879
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. CHEK2-positive breast cancers in young Polish women.
    Cybulski C, Górski B, Huzarski T, Byrski T, Gronwald J, Debniak T, Wokolorczyk D, Jakubowska A, Kowalska E, Oszurek O, Narod SA, Lubinski J.
    Clin Cancer Res; 2006 Aug 15; 12(16):4832-5. PubMed ID: 16914568
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Identification of a novel CHEK2 variant and assessment of its contribution to the risk of breast cancer in French Canadian women.
    Novak DJ, Chen LQ, Ghadirian P, Hamel N, Zhang P, Rossiny V, Cardinal G, Robidoux A, Tonin PN, Rousseau F, Narod SA, Foulkes WD.
    BMC Cancer; 2008 Aug 15; 8():239. PubMed ID: 18706089
    [Abstract] [Full Text] [Related]

  • 27. Epistatic relationship between the cancer susceptibility genes CHEK2 and p27.
    Cybulski C, Gliniewicz B, Sikorski A, Kładny J, Huzarski T, Gronwald J, Byrski T, Debniak T, Gorski B, Jakubowska A, Wokolorczyk D, Narod SA, Lubiñski J.
    Cancer Epidemiol Biomarkers Prev; 2007 Mar 15; 16(3):572-6. PubMed ID: 17372254
    [Abstract] [Full Text] [Related]

  • 28. Mutations in CHEK2 associated with prostate cancer risk.
    Dong X, Wang L, Taniguchi K, Wang X, Cunningham JM, McDonnell SK, Qian C, Marks AF, Slager SL, Peterson BJ, Smith DI, Cheville JC, Blute ML, Jacobsen SJ, Schaid DJ, Tindall DJ, Thibodeau SN, Liu W.
    Am J Hum Genet; 2003 Feb 15; 72(2):270-80. PubMed ID: 12533788
    [Abstract] [Full Text] [Related]

  • 29. Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.
    Laitman Y, Kaufman B, Lahad EL, Papa MZ, Friedman E.
    Isr Med Assoc J; 2007 Nov 15; 9(11):791-6. PubMed ID: 18085035
    [Abstract] [Full Text] [Related]

  • 30. A simple method of investigating mutations in CHEK2 by DHPLC: a study of the German populations of Saxony, Saxony-Anhalt, and Thuringia.
    Scharrer U, Skrzypczak-Zielinska M, Wituszynska W, Mierzejewski M, Krause K, Cybulski C, Froster UG.
    Cancer Genet Cytogenet; 2010 May 15; 199(1):48-52. PubMed ID: 20417869
    [Abstract] [Full Text] [Related]

  • 31. Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.
    van Puijenbroek M, van Asperen CJ, van Mil A, Devilee P, van Wezel T, Morreau H.
    J Pathol; 2005 Jun 15; 206(2):198-204. PubMed ID: 15818573
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study.
    Johnson N, Fletcher O, Naceur-Lombardelli C, dos Santos Silva I, Ashworth A, Peto J.
    Lancet; 2005 Jun 15; 366(9496):1554-7. PubMed ID: 16257342
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. CHEK2 Founder Variants and Thyroid Cancer Risk.
    Brock P, Liynarachchi S, Nieminen TT, Chan C, Kohlmann W, Stout LA, Yao S, La Greca A, Jensen KE, Kolesar JM, Salhia B, Gulhati P, Hicks JK, Ringel MD.
    Thyroid; 2024 Apr 15; 34(4):477-483. PubMed ID: 38279823
    [Abstract] [Full Text] [Related]

  • 37. Comparing Cancer Risk Management between Females with Truncating CHEK2 1100delC versus Missense CHEK2 I157T Variants.
    Garmendia D, Weidner A, Venton L, Pal T.
    Genes (Basel); 2024 Jul 05; 15(7):. PubMed ID: 39062660
    [Abstract] [Full Text] [Related]

  • 38. Pathology of breast cancer in women with constitutional CHEK2 mutations.
    Huzarski T, Cybulski C, Domagała W, Gronwald J, Byrski T, Szwiec M, Woyke S, Narod SA, Lubiński J.
    Breast Cancer Res Treat; 2005 Mar 05; 90(2):187-9. PubMed ID: 15803365
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Limited relevance of the CHEK2 gene in hereditary breast cancer.
    Dufault MR, Betz B, Wappenschmidt B, Hofmann W, Bandick K, Golla A, Pietschmann A, Nestle-Krämling C, Rhiem K, Hüttner C, von Lindern C, Dall P, Kiechle M, Untch M, Jonat W, Meindl A, Scherneck S, Niederacher D, Schmutzler RK, Arnold N.
    Int J Cancer; 2004 Jun 20; 110(3):320-5. PubMed ID: 15095295
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.